361 related articles for article (PubMed ID: 10095883)
1. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
Zimmermann R; Faure M; Claudy A
Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
[TBL] [Abstract][Full Text] [Related]
3. [Pemphigoid gestationis: treatment by topical class I corticosteroid].
Valeyrie L; Lebrun-Vignes B; Bodak N; Grossin M; Descamps V; Crickx B; Bélaïch S
Ann Dermatol Venereol; 2001 May; 128(5):638-40. PubMed ID: 11427799
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid treated by topical corticosteroids.
Paquet P; Richelle M; Lapiere CM
Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroids and bullous pemphigoid.
Hull CM; McKenna JK; Zone JJ
Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
[No Abstract] [Full Text] [Related]
6. Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
[TBL] [Abstract][Full Text] [Related]
8. Whole body application of a potent topical corticosteroid for bullous pemphigoid.
Terra JB; Potze WJ; Jonkman MF
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bullous pemphigoid with topical clobetasol propionate.
Westerhof W
J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
[TBL] [Abstract][Full Text] [Related]
11. [Kaposi's disease: an unusual side-effect of topical corticosteroids].
Boudhir H; Mael-Ainin M; Senouci K; Hassam B; Benzekri L
Ann Dermatol Venereol; 2013; 140(6-7):459-61. PubMed ID: 23773746
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Morales-Garcia P; Mesa-Aguado F; Bascones-Martinez A; Bravo M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):688-92. PubMed ID: 12789149
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of phimosis with locally applied 0.05% clobetasol propionate. Prospective study with 108 children].
Iken A; Ben Mouelli S; Fontaine E; Quenneville V; Thomas L; Beurton D
Prog Urol; 2002 Dec; 12(6):1268-71. PubMed ID: 12545636
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
Kjellman P; Eriksson H; Berg P
Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
[TBL] [Abstract][Full Text] [Related]
16. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P; Roujeau JC; Benichou J; Delaporte E; D'Incan M; Dreno B; Bedane C; Sparsa A; Gorin I; Picard C; Tancrede-Bohin E; Sassolas B; Lok C; Guillaume JC; Doutre MS; Richard MA; Caux F; Prost C; Plantin P; Chosidow O; Pauwels C; Maillard H; Saiag P; Descamps V; Chevrant-Breton J; Dereure O; Hellot MF; Esteve E; Bernard P
J Invest Dermatol; 2009 Jul; 129(7):1681-7. PubMed ID: 19177141
[TBL] [Abstract][Full Text] [Related]
18. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
[No Abstract] [Full Text] [Related]
19. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
20. [One year follow-up of patients with bullous pemphigoid].
Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
